Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

This meta-analysis pooled 25 randomized controlled trials of weight reduction interventions to quantify the effect of intentional weight loss on systolic and diastolic blood pressure in 4,874 participants.

Each kilogram of weight loss was associated with approximately 1 mmHg reduction in systolic blood pressure and 1 mmHg in diastolic blood pressure. The relationship was dose-dependent: greater weight loss produced greater blood pressure reduction. The effect was independent of sodium restriction and was observed in both hypertensive and normotensive individuals.

The clinical relevance is straightforward. Weight reduction is a proven antihypertensive intervention, and this analysis provides the quantitative basis for counseling patients about what level of weight loss is needed to achieve a meaningful blood pressure reduction. For a patient needing 5–10 mmHg blood pressure reduction, a weight loss of 5–10 kg provides a plausible path without pharmacotherapy — or enables dose reduction in patients already on antihypertensives.

Given hypertension’s contribution to cardiovascular risk, this meta-analysis supports weight management as a first-line intervention for blood pressure control and a meaningful component of comprehensive cardiovascular risk reduction.

We rate the evidence strong. A rigorous pooled analysis of RCTs establishing dose-dependent blood pressure reduction with weight loss — foundational evidence for lifestyle-based cardiovascular risk management.